• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国香港肝细胞癌肝移植的现状

Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China.

作者信息

Ho Karin, Chan Albert

机构信息

Liver Transplant Center, Queen Mary Hospital, Department of Surgery, The University of Hong Kong, Hong Kong, China.

Liver Transplant Center, Queen Mary Hospital, Department of Surgery, The University of Hong Kong, Hong Kong, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2025 Feb;24(1):45-49. doi: 10.1016/j.hbpd.2024.09.005. Epub 2024 Sep 13.

DOI:10.1016/j.hbpd.2024.09.005
PMID:39307663
Abstract

With the advances in transplant oncology in recent years, the role of liver transplantation has expanded to make curative treatment a possibility for a wider patient population. We highlight strategies in Hong Kong, China that have enabled preoperative prognostication for judicious patient selection, downstaging therapy to definitive treatment, and postoperative therapies that have provided a growing role for liver transplantation in patients with more advanced hepatocellular carcinoma.

摘要

近年来,随着移植肿瘤学的进展,肝移植的作用不断扩大,使更多患者有可能获得治愈性治疗。我们重点介绍了中国香港的一些策略,这些策略能够实现术前预后评估以明智地选择患者、进行降期治疗以过渡到确定性治疗,以及术后治疗,这些都使得肝移植在晚期肝细胞癌患者中的作用日益重要。

相似文献

1
Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China.中国香港肝细胞癌肝移植的现状
Hepatobiliary Pancreat Dis Int. 2025 Feb;24(1):45-49. doi: 10.1016/j.hbpd.2024.09.005. Epub 2024 Sep 13.
2
Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.韩国肝细胞癌活体供肝移植的现状
Transplant Proc. 2012 Mar;44(2):520-2. doi: 10.1016/j.transproceed.2012.02.003.
3
Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.第 3 节:肝移植前肝癌降期的现状。
Transplantation. 2014 Apr 27;97 Suppl 8:S10-7. doi: 10.1097/01.tp.0000446267.19148.21.
4
Downstaging of hepatocellular carcinoma before transplantation: an advance in therapy or just another selection criterion.
Am J Transplant. 2008 Dec;8(12):2485-6. doi: 10.1111/j.1600-6143.2008.02466.x.
5
Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.超出米兰标准的肝细胞癌肝移植
Exp Clin Transplant. 2017 Mar;15(Suppl 2):59-64. doi: 10.6002/ect.TOND16.L16.
6
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.肝细胞癌肝移植候选者选择及扩展标准概述:一项综述与共识声明
Liver Transpl. 2011 Oct;17 Suppl 2:S81-9. doi: 10.1002/lt.22380.
7
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.肝细胞癌肝移植中的米兰标准:基于15年经验的循证分析
Liver Transpl. 2011 Oct;17 Suppl 2:S44-57. doi: 10.1002/lt.22365.
8
Hepatocellular carcinoma and liver transplantation.肝细胞癌与肝移植。
Curr Opin Organ Transplant. 2011 Jun;16(3):297-300. doi: 10.1097/MOT.0b013e3283465756.
9
Liver transplantation for hepatocellular carcinoma.肝移植治疗肝细胞癌。
Abdom Radiol (NY). 2018 Jan;43(1):185-192. doi: 10.1007/s00261-017-1217-1.
10
Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?肝细胞癌的肝移植标准在尸体供肝和活体供肝中是否应该有所不同?
Liver Transpl. 2011 Oct;17 Suppl 2:S133-8. doi: 10.1002/lt.22348.

引用本文的文献

1
Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1.水苏糖在肝细胞癌中的关键分子靶点鉴定:聚焦于信号转导和转录激活因子3(STAT3)及纤连蛋白1(FN1)
Front Oncol. 2025 Jul 23;15:1576449. doi: 10.3389/fonc.2025.1576449. eCollection 2025.